The results reported here indicate a striking modifier function of NEDD9 on the activity of ATM kinase and related signaling in KRAS/TP53 mutated NSCLC, with its effects on the regulation of both DDR and EMT processes, sensitivity to DNA damaging modalities, and the survival of the patients. This evidence concerns the gene KRAS and non-small cell lung carcinoma.